World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 86 1261 1147 658 586 178 27881
Medicine 86 14109 13285 7156 6623 178 27881

Jeffrey D. Lifson publications per year

The chart shows the history of publications by Jeffrey D. Lifson between 1997 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Jeffrey D. Lifson published across 29 years, from 1997 to 2025, averaging 8.1 papers a year. Output peaked at 20 publications in 2009. 31 of the 235 publications appeared in the last two years.

No. of publications
5 10 15 20
Bar chart. Horizontal axis: year, 1997 to 2025. Vertical axis: number of publications, 0 to 20. Peak 20 publications in 2009. 1997: 1 publication 1998: 1 publication 1999: 5 publications 2000: 8 publications 2001: 5 publications 2002: 6 publications 2003: 13 publications 2004: 10 publications 2005: 7 publications 2006: 11 publications 2007: 11 publications 2008: 13 publications 2009: 20 publications 2010: 14 publications 2011: 13 publications 2012: 12 publications 2013: 20 publications 2014: 4 publications 2015: 1 publication 2016: 1 publication 2017: 0 publications 2018: 0 publications 2019: 0 publications 2020: 0 publications 2021: 2 publications 2022: 12 publications 2023: 14 publications 2024: 14 publications 2025: 17 publications
1997 2025

235 publications in total across all disciplines

View publications per year as a table
Jeffrey D. Lifson: publications per year, 1997 to 2025
Year Publications
1997 1
1998 1
1999 5
2000 8
2001 5
2002 6
2003 13
2004 10
2005 7
2006 11
2007 11
2008 13
2009 20
2010 14
2011 13
2012 12
2013 20
2014 4
2015 1
2016 1
2017 0
2018 0
2019 0
2020 0
2021 2
2022 12
2023 14
2024 14
2025 17
Total 235
Download as CSV

Jeffrey D. Lifson publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jeffrey D. Lifson sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 172–181 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 178 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181 178
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Jeffrey D. Lifson D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey D. Lifson sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 86–87 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 86 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102 86
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Jeffrey D. Lifson is affiliated with Leidos in the United States and has contributed extensively to the fields of immunology, microbiology, and medicine. The scientist's primary research interests focus on HIV research and treatment, immune cell function and interaction, and herpesvirus infections. Lifson's work notably spans subfields such as virology, immunology, epidemiology, infectious diseases, and genetics.

The scientist's published papers cover a range of topics central to HIV/AIDS and immune system interactions. Notable recent papers include:

  • Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo (2020, Nature)
  • Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells (2020, Nature)
  • CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption (2020, Nature Medicine)
  • Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy (2022, Science Translational Medicine)
  • Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody (2020, Proceedings of the National Academy of Sciences)

Frequent coauthors include Brandon F. Keele, Christine M. Fennessey, Louis J. Picker, Guido Silvestri, and Rebecca Shoemaker. Collaborations with these researchers have contributed to a significant body of work in the field of HIV and immunology.

Lifson has published numerous articles in various scientific venues. The primary venues for publication include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • PLoS Pathogens
  • Nature
  • UNC Libraries
  • Journal of Virology

The scientist's main topics of research focus on:

  • HIV Research and Treatment
  • Immune Cell Function and Interaction
  • Cytomegalovirus and herpesvirus research
  • Herpesvirus Infections and Treatments
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • T-cell and B-cell Immunology

Jeffrey D. Lifson's work integrates detailed investigations into viral latency and immune response mechanisms, frequently addressing questions central to viral reactivation and immune checkpoint modulation. This includes research into immune therapies and neutralizing antibodies relevant to managing HIV and other viral infections.

Best Publications

  • Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine

    Scott G. Hansen;Julia C. Ford;Matthew S. Lewis;Abigail B. Ventura

  • Distribution and three-dimensional structure of AIDS virus envelope spikes

    Ping Zhu;Jun Liu;Julian Bess;Elena Chertova

  • Glycerol monolaurate prevents mucosal SIV transmission

    Qingsheng Li;Jacob D. Estes;Patrick M. Schlievert;Lijie Duan

  • Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

    Scott G Hansen;Cassandra Vieville;Nathan Whizin;Lia Coyne-Johnson

  • Immune clearance of highly pathogenic SIV infection

    Scott G. Hansen;Michael Piatak;Abigail B. Ventura;Colette M. Hughes

  • Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1

    Angela Meier;J Judy Chang;Ellen S Chan;Richard B Pollard

  • Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections

    Jacob D. Estes;Levelle D. Harris;Nichole R. Klatt;Brian Tabb

  • Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia

    Masashi Shingai;Yoshiaki Nishimura;Florian Klein;Hugo Mouquet

  • Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes

    Galit Alter;Maureen P. Martin;Nickolas Teigen;William H Carr

  • Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions.

    Ping Zhu;Elena Chertova;Julian Bess;Jeffrey D. Lifson

  • Cytomegalovirus Vectors Violate CD8+ T Cell Epitope Recognition Paradigms

    Scott G. Hansen;Jonah B. Sacha;Colette M. Hughes;Julia C. Ford

  • Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5

    Michael M Lederman;Ronald S Veazey;Robin Ewart Offord;Donald E Mosier

  • Effectiveness of Postinoculation (R)-9-(2-Phosphonylmethoxypropyl)Adenine Treatment for Prevention of Persistent Simian Immunodeficiency Virus SIVmne Infection Depends Critically on Timing of Initiation and Duration of Treatment

    Che-Chung Tsai;Peter Emau;Kathryn E. Follis;Thomas W. Beck

  • Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS.

    A. Nichole Cline;Julian W. Bess;Michael Jr Piatak;Jeffrey D. Lifson

  • Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus Replication

    John T. Loffredo;Jess Maxwell;Ying Qi;Chrystal E. Glidden

  • Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells

    Jean-François Fonteneau;Marie Larsson;Anne-Sophie Beignon;Kelli McKenna

  • Envelope Glycoprotein Incorporation, Not Shedding of Surface Envelope Glycoprotein (gp120/SU), Is the Primary Determinant of SU Content of Purified Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus

    Elena Chertova;Julian W. Bess;Bruce J. Crise;Raymond C. Sowder

  • Influence of HLA-C Expression Level on HIV Control

    Richard Apps;Richard Apps;Ying Qi;Ying Qi;Jonathan M. Carlson;Haoyan Chen;Haoyan Chen

  • Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections

    Ming Zeng;Anthony J. Smith;Stephen W. Wietgrefe;Peter J. Southern

  • Insufficient Production and Tissue Delivery of CD4+Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection

    Louis J. Picker;Shoko I. Hagen;Richard Lum;Edward F. Reed-Inderbitzin

  • The High-Frequency Major Histocompatibility Complex Class I Allele Mamu-B*17 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication

    Levi J. Yant;Thomas C. Friedrich;Randall C. Johnson;Gemma E. May

Frequent Co-Authors

Michael Piatak
Michael Piatak Leidos (United States)
Ronald C. Desrosiers
Ronald C. Desrosiers University of Miami
R. Paul Johnson
R. Paul Johnson Emory University
Jacob D. Estes
Jacob D. Estes Oregon Health & Science University
Louis J. Picker
Louis J. Picker Oregon Health & Science University
David C. Montefiori
David C. Montefiori Duke University
Michael K. Axthelm
Michael K. Axthelm Oregon National Primate Research Center
Agegnehu Gettie
Agegnehu Gettie Aaron Diamond AIDS Research Center
Brandon F. Keele
Brandon F. Keele National Institutes of Health
James Blanchard
James Blanchard Tulane University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers. For those interested in combining clinical practice with immunological knowledge, becoming a Nurse Practitioner (NP) is a promising path. If you are a Family Nurse Practitioner considering advanced roles, understanding how to transition from FNP to acute care NP can be a critical step for career growth and specialization in immune-related acute conditions.

For aspiring NPs seeking to expedite their education, finding the right nurse practitioner accelerated program online is essential. These programs cater to professionals aiming to reduce the time to practice while gaining the advanced training needed for patient care in immunology-related fields.

If you are new to nursing but eager to enter the field quickly, exploring the best online RN programs for non nurses provides accessible pathways to start clinical roles that often intersect with immunology, such as infection control and immunization programs.

Additionally, many students benefit from easier entry options by enrolling in the easiest ABSN programs to get into. These accelerated Bachelor of Science in Nursing programs allow faster transitions from non-nursing backgrounds, helping students enter the healthcare workforce sooner and pursue further specialization in immunological disciplines.

Best Scientists Citing Jeffrey D. Lifson

Trending Scientists

Recently Published Articles